Evaluation of drugs prescribed by physicians and their adherence to guidelines used in treatment of cancer related neuropathic pain.
- Conditions
- Health Condition 1: null- Cancer patients experiencing Neuropathic Pain
- Registration Number
- CTRI/2017/03/008062
- Lead Sponsor
- Dr Vishal Singh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 291
1. Patients of either gender and age above of 18 years and below 80 years experiencing from neuropathic pain due to any cancer.
2. Patients diagnosed by treating physicians as having neuropathic pain using the screening tool DN4 Neuropathic pain diagnostic questionnaire with score >= 4
3. Patients willing to give voluntary informed consent.
1. Patients with established diagnosis of neurogenic pain associated with localized peripheral neuropathies (e.g. Post herpetic neuralgia, Diabetic neuropathy, Post- surgical/traumatic neuropathic pain.)
2. Patients unable to comprehend the patient information sheet.
3. Patients diagnosed with fibromyalgia.
4. Any other medical condition, which in the opinion of the investigator precludes the
inclusion of the participant.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method